REFERENCES
- Roberts M.S., Walters K.A. The Relationship Between Structure and Barrier Function of Skin. Dermal Absorption and Toxicity Assessment, M.S. Roberts, K.A. Walters. Marcel Dekker, New York 1998
- Scheuplein R. Permeability of the Skin: A Review of Major Concepts. Curr. Probl. Dermatol. 1978; 7: 172–186, [PUBMED], [INFOTRIEVE]
- Crank J. The Mathematics of Diffusion. 2nd Ed., Clarendon Press, Oxford 1975
- Yano Y., Yamaoka K., Aoyama Y., Tanaka H. Two-Compartment Dispersion Model for Analysis of Organ Perfusion System of Drugs by Fast Inverse Laplace Transform (FILT). J. Pharmacokinet. Biopharm. 1989; 17: 179–202, [PUBMED], [INFOTRIEVE]
- Yano Y., Yamaoka K., Tanaka H. A Non-Linear Least Squares Program, MULTI(FILT), Based on Fast Inverse Laplace Transform (FILT) for Microcomputers. Chem. Pharm. Bull. 1989; 37: 1535–1538
- Purves R.D. Accuracy of Numerical Inversions of Laplace Transforms for Pharmacokinetic Parameter Estimation. J. Pharm. Sci. 1995; 84: 71–74, [PUBMED], [INFOTRIEVE]
- Pirot F., Kalia Y.N., Stinchcomb A.L., Keating G., Bunge A., Guy R.H. Characterization of the Permeability Barrier of Human Skin In Vivo. Proc. Natl. Acad. Sci. USA 1997; 94(4)1562–1567, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Siddiqui O., Roberts M.S., Polack A.E. Percutaneous Absorption of Steroids Relative Contributions of Epidermal Penetration and Dermal Clearance. J. Pharmacokinet. Biopharm. 1989; 17(Aug)405–424, [PUBMED], [INFOTRIEVE]
- Roberts M.S. Structure-Permeability Considerations in Percutaneous Absorption. Prediction of Percutaneous Penetration, R.C. Scott, R.H. Guy, J. Hadgraft. IBC Technical Services, London 1991; Vol. 2
- Parry G.E., Bunge A.L., Silcox G.D., Pershing L.K., Pershing D.W. Percutaneous Absorption of Benzoic Acid Across Human Skin. In Vitro Experiments and Mathematical Modeling. Pharm. Res. 1990; 7(3)230–236, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Scheuplein R.J., Blank I.H. Mechanism of Percutaneous Absorption. IV: Penetration of Nonelectrolytes (Alcohols) from Aqueous Solutions and from Pure Liquids. J. Investig. Dermatol. 1973; 60: 286–296, [CROSSREF]
- Roberts M.S., Anderson R.A., Swarbrick J., Moore D.E. The Percutaneous Absorption of Phenolic Compounds: The Mechanism of Diffusion Across the Stratum Corneum. J. Pharm. Pharmacol. 1978; 30(8)486–490, [PUBMED], [INFOTRIEVE]
- Guy R.H., Hadgraft J. Physicochemical Interpretation of the Pharmacokinetics of Percutaneous Absorption. J. Pharmacokinet. Biopharm. 1983; 11(2)189–203, [PUBMED], [INFOTRIEVE]
- Kubota K., Ishizaki T. A Theoretical Consideration of Percutaneous Drug Absorption. J. Pharmacokinet. Biopharm. 1985; 13(1)55–72, [PUBMED], [INFOTRIEVE]
- Scheuplein R.J., Ross L.W. Mechanism of Percutaneous Absorption. V: Percutaneous Absorption of Solvent Deposited Solids. J. Investig. Dermatol. 1974; 62: 353–360, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Kakemi K., Kameda H., Kakemi M., Ueda M., Koizumi T. Model Studies on Percutaneous Absorption and Transport in the Ointment. I: Theoretical Aspects. Chem. Pharm. Bull. 1975; 23(9)2109–2113, [PUBMED], [INFOTRIEVE]
- Guy R.H., Hadgraft J. Theoretical Description Relating Skin Penetration to the Thickness of the Applied Medicament. Int. J. Pharm. 1980; 6: 321–332, [CROSSREF]
- Kubota K., Ishizaki T. A Diffusion–Diffusion Model for Percutaneous Drug Absorption. J. Pharmacokinet. Biopharm. 1986; 14(4)409–439, [PUBMED], [INFOTRIEVE]
- Kubota K., Yamada T. Finite Dose Percutaneous Drug Absorption: Theory and Its Application to In Vitro Timolol Permeation. J. Pharm. Sci. 1990; 79(11)1015–1019, [PUBMED], [INFOTRIEVE]
- Hadgraft J. The Epidermal Reservoir: A Theoretical Approach. Int. J. Pharm. 1979; 2: 265–274, [CROSSREF]
- Cleek R.L., Bunge A.L. A New Method for Estimating Dermal Absorption from Chemical Exposure. 1: General Approach. Pharm. Res. 1993; 10(4)497–506, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Bunge A.L., Cleek R.L. A New Method for Estimating Dermal Absorption From Chemical Exposure. 2: Effect of Molecular Weight and Octanol–Water Partitioning. Pharm. Res. 1995; 12(1)88–95, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Hadgraft J. Calculations of Drug Release Rates from Controlled Release Devices. The Slab. Int. J. Pharm. 1979; 2: 177–194, [CROSSREF]
- Chandrasekaran S.K., Bayne W., Shaw J.E. Pharmacokinetics of Drug Permeation Through Human Skin. J. Pharm. Sci. 1978; 67(10)1370–1374, [PUBMED], [INFOTRIEVE]
- Higuchi W.I. Diffusional Models Useful in Biopharmaceutics. Drug Release Rate Process. J. Pharm. Sci. 1967; 56(3)315–324
- Riegelman S. Pharmacokinetics. Pharmacokinetic Factors Affecting Epidermal Penetration and Percutaneous Adsorption. Clin. Pharmacol. Ther. 1974; 16((5, Part 2)873–883, [PUBMED], [INFOTRIEVE]
- Wallace S.M., Barnett G. Pharmacokinetic Analysis of Percutaneous Absorption: Evidence of Parallel Penetration Pathways for Methotrexate. J. Pharmacokinet. Biopharm. 1978; 6(4)315–325, [PUBMED], [INFOTRIEVE]
- Guy R.H., Hadgraft J. Prediction of Drug Disposition Kinetics in Skin and Plasma Following Topical Administration. J. Pharm. Sci. 1984; 73(7)883–887, [PUBMED], [INFOTRIEVE]
- Kubota K. A Compartment Model for Percutaneous Drug Absorption. J. Pharm. Sci. 1991; 80(5)502–504, [PUBMED], [INFOTRIEVE]
- Shah J.C. Application of Kinetic Model to In Vitro Percutaneous Permeation of Drugs. Int. J. Pharm. 1996; 133: 179–189, [CROSSREF]
- Guy R.H., Hadgraft J., Maibach H.I. A Pharmacokinetic Model for Percutaneous Absorption. Int. J. Pharm. 1982; 11: 119–129, [CROSSREF]
- Walters K.A., Roberts M.S., Gettings S. Percutaneous Absorption of Sunscreens. Percutaneous Absorption, R. Bronaugh, H.I. Maibach. 3rd Ed., Marcel Dekker, New York 1998
- Guy R.H., Hadgraft J., Maibach H.I. Percutaneous Absorption: Multidose Pharmacokinetics. Int. J. Pharm. 1983; 17: 23–28, [CROSSREF]
- Kubota K., Koyama E., Yasuda K. Random Walk Method for Percutaneous Drug Absorption Pharmacokinetics: Application to Repeated Administration of a Therapeutic Timolol Patch. J. Pharm. Sci. 1991; 80(8)752–756, [PUBMED], [INFOTRIEVE]
- Guy R.H., Hadgraft J. The Effect of Penetration Enhancers on the Kinetics of Percutaneous Absorption. J. Control. Release 1987; 5: 43–51, [CROSSREF]
- Kubota K., Maibach H.I. Compartment Model for Percutaneous Absorption: Compatibility of Lag Time and Steady-State Flux with Diffusion Model. J. Pharm. Sci. 1992; 81(9)863–865, [PUBMED], [INFOTRIEVE]
- McCarley K.D., Bunge A.L. Physiologically Relevant One-Compartment Pharmacokinetic Models for Skin. 1: Development of Models. J. Pharm. Sci. 1998; 87(4)470–481, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Roberts M.S., Anderson R.A., Swarbrick J. Permeability of Human Epidermis to Phenolic Compounds. J. Pharm. Pharmacol. 1977; 29(11)677–683, [PUBMED], [INFOTRIEVE]
- Wu M.S. Determination of Concentration-Dependent Water Diffusivity in a Keratinous Membrane. J. Pharm. Sci. 1983; 72(12)1421–1423, [PUBMED], [INFOTRIEVE]
- Giengler G., Knoch A., Merkle H.P. Modeling and Numerical Computation of Drug Transport in Laminates: Model Case Evaluation of Transdermal Delivery System. J. Pharm. Sci. 1986; 75(1)9–15
- Higuchi W.I., Higuchi T. Theoretical Analysis of Diffusional Movements Through Heterogeneous Barriers. J. Am. Pharm. Assoc. Sci. Ed. 1960; 49(9)598–606
- Chandrasekaran S.K., Michaels A.S., Campbell P.S., Shaw J.E. Scopolamine Permeation Through Human Skin In Vitro. AIChE J. 1976; 22(5)828–832, [CROSSREF]
- Kubota K., Koyama E., Twizell E.H. Dual Sorption Model for the Nonlinear Percutaneous Permeation Kinetics of Timolol. J. Pharm. Sci. 1993; 82(12)1205–1208, [PUBMED], [INFOTRIEVE]
- Ando H.Y., Ho N.F.H., Higuchi W.I. Skin as an Active Metabolising Barrier. 1: Theoretical Analysis of Topical Bioavailability. J. Pharm. Sci. 1977; 66(11)1525–1528, [PUBMED], [INFOTRIEVE]
- Yu C.D., Fox J.L., Ho N.F.H., Higuchi W.I. Physical Model Evaluation of Topical Prodrug Delivery—Simultaneous Transport and Bioconversion of Vidarabine 5′-Valerate. Part 1: Physical Model Development. J. Pharm. Sci. 1979; 68(11)1341–1346, [PUBMED], [INFOTRIEVE]
- Yu C.D., Fox J.L., Ho N.F.H., Higuchi W.I. Physical Model Evaluation of Topical Prodrug Delivery—Simultaneous Transport and Bioconversion of Vidarabine 5′-Valerate. Part 2: Parameter Determinations. J. Pharm. Sci. 1979; 68(11)1347–1357, [PUBMED], [INFOTRIEVE]
- Yu C.D., Gordon N.A., Fox J.L., Higuchi W.I., Ho N.F.H. Physical Model Evaluation of Topical Prodrug Delivery—Simultaneous Transport and Bioconversion of Vidarabine 5′-Valerate. Part 5: Mechanistic Analysis of Influence of Nonhomogeneous Enzyme Distributions in Hairless Mouse Skin. J. Pharm. Sci. 1980; 69(7)775–780, [PUBMED], [INFOTRIEVE]
- Fox J.L., Yu C.D., Higuchi W.I., Ho N.F.H. General Physical Model for Simultaneous Diffusion and Metabolism in Biological Membranes. Computational Approach for the Steady State Case. Int. J. Pharm. 1979; 2: 41–57, [CROSSREF]
- Hadgraft J. Theoretical Aspects of Metabolism in the Epidermis. Int. J. Pharm. 1980; 4: 229–239, [CROSSREF]
- Guy R.H., Hadgraft J. Percutaneous Metabolism with Saturable Enzyme Kinetics. Int. J. Pharm. 1982; 11: 187–197, [CROSSREF]
- Kubota K., Ademola J., Maibach H.I. Simultaneous Diffusion and Metabolism of Betamethasone 17-Valerate in the Living Skin Equivalent. J. Pharm. Sci. 1995; 84(12)1478–1481, [PUBMED], [INFOTRIEVE]
- Guy R.H., Hadgraft J. Pharmacokinetics of Percutaneous Absorption with Concurrent Metabolism. Int. J. Pharm. 1984; 20: 43–51, [CROSSREF]
- Hadgraft J., Wolff H.M. In Vitro/In Vivo Correlations in Transdermal Drug Delivery. Dermal Absorption and Toxicity Assessment, M.S. Roberts, K.A. Walters. Marcel Dekker, New York 1998
- Robinson P.J. Prediction: Simple Risk Models and Overview of Dermal Risk Assessment. Dermal Absorption and Toxicity Assessment, M.S. Roberts, K.A. Walters. Marcel Dekker, New York 1998
- Pugh W.J., Hadgraft J., Roberts M.S. Physicochemical Determinants of Stratum Corneum Permeation. Dermal Absorption and Toxicity Assessment, M.S. Roberts, K.A. Walters. Marcel Dekker, New York 1998
- Reifenrath W.G., Robinson P.B. In Vitro Skin Evaporation and Penetration Characteristics of Mosquito Repellents. J. Pharm. Sci. 1982; 71(9)1014–1018, [PUBMED], [INFOTRIEVE]
- Guy R.H., Hadgraft J. A Theoretical Description of the Effects of Volatility and Substantivity on Percutaneous Absorption. Int. J. Pharm. 1984; 18: 139–147, [CROSSREF]
- Guy R.H., Hadgraft J. Percutaneous Absorption Kinetics of Topically Applied Agents Liable to Surface Loss. J. Soc. Cosmet. Chem. 1984; 35: 103–113
- Scheuplein R.J. Mechanism of Percutaneous Absorption. II: Transient Diffusion and the Relative Importance of Various Routes of Skin Penetration. J. Investig. Dermatol. 1967; 48(1)79–88, [PUBMED], [INFOTRIEVE]
- Ghanem A.H., Mahmoud H., Higuchi W.I., Rohr U.D., Borsadia S., Liu P., Fox J.L., Good W.R. The Effects of Ethanol on the Transport of b Estradiol and Other Permeants in the Hairless Mouse Skin. II: A New Quantitative Approach. J. Control. Release 1987; 6: 75–83, [CROSSREF]
- Hatanaka T., Inuma M., Sugibayashi K., Morimoto Y. Prediction of Skin Permeability of Drugs. II: Development of Composite Membrane as a Skin Alternative. Int. J. Pharm. 1990; 79: 3452–3459
- Tojo K., Chiang C.C., Chien Y.W. Drug Permeation Across the Skin: Effect of Penetrant Hydrophilicity. J. Pharm. Sci. 1987; 76(2)123–126, [PUBMED], [INFOTRIEVE]
- Yamashita F., Yoshioka T., Koyama Y., Okamoto H., Sezaki H., Hashida M. Analysis of Skin Penetration Enhancement Based on a Two Layer Skin Diffusion Model with Polar and Nonpolar Routes in the Stratum Corneum: Dose-Dependent Effect of 1-Geranylazacycloheptan-2-One on Drugs with Different Lipophilicities. Biol. Pharm. Bull. 1993; 16(7)690–697, [PUBMED], [INFOTRIEVE]
- Edwards D.A., Langer R. A Linear Theory of Transdermal Transport Phenomena. J. Pharm. Sci. 1994; 83(9)1315–1334, [PUBMED], [INFOTRIEVE]
- Rohatagi S., Barrett J.S., Dewitt K.E., Morales R.J. Integrated Pharmacokinetics and Metabolic Modeling of Selegiline and Metabolites After Transdermal Administration. Biopharm. Drug Dispos. 1997; 18(7)567–584, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Cross S.E., Wu Z.Y., Roberts M.S. Effect of Perfusion Flow Rate on the Tissue Uptake of Solutes After Dermal Application Using the Rat Isolated Perfused Hindlimb Preparation. J. Pharm. Pharmacol. 1994; 46: 844–850, [PUBMED], [INFOTRIEVE]
- Cross S.E., Wu Z.Y., Roberts M.S. The Effect of Protein Binding on the Deep Tissue Penetration and Elution of Transdermally Applied Water, Salicyclic Acid, Lignocaine and Diazepam in the Perfused Rat. J. Pharmacol. Exp. Ther. 1996; 277: 366–374, [PUBMED], [INFOTRIEVE]
- Williams P.L., Carver M.P., Riviere J.E. A Physiologically Relevant Pharmacokinetic Model of Xenobiotic Percutaneous Absorption Using the Isolated Perfused Porcine Skin Flap. J. Pharm. Sci. 1990; 79(4)305–311, [PUBMED], [INFOTRIEVE]
- Reddy M.B., McCarley K.D., Bunge A.L. Physiologically Relevant One-Compartment Pharmacokinetic Model for Skin. 2: Comparison of Models When Combined with a Systemic Pharmacokinetic Model. J. Pharm. Sci. 1998; 87(4)482–490, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Roberts M.S., Lipschitz S., Campbell A.J., Wanwimolruk S., McQueen E.G., McQueen M. Modeling of Subcutaneous Absorption Kinetics of Infusion Solutions in the Elderly Using Technetium. J. Pharmacokinet. Biopharm. 1997; 25(1)1–19, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Singh P., Roberts M.S., Maibach H.I. Modeling of Plasma Levels of Drugs Following Transdermal Iontophoresis. J. Control. Release 1995; 33: 293–298, [CROSSREF]
- Imanidis G., Song W., Lee P.H., Su M.H., Kern E.R., Higuchi W.I. Estimation of Skin Target Site Acyclovir Concentrations Following Controlled Transdermal Drug Delivery in Topical and Systemic Treatment of Cutaneous HSV-I Infections in Hairless Mice. Pharm. Res. 1994; 11(7)1035–1041, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Cooper E.R. Pharmacokinetics of Skin Penetration. J. Pharm. Sci. 1976; 65(9)1396–1397, [PUBMED], [INFOTRIEVE]
- Cooper E.R. Effect of Diffusional Lag Time on Multicompartmental Pharmacokinetics for Transepidermal Infusion. J. Pharm. Sci. 1979; 68(11)1469–1470, [PUBMED], [INFOTRIEVE]
- Cooper E.R., Berner B. Finite Dose Pharmacokinetics of Skin Penetration. J. Pharm. Sci. 1985; 74(10)1100–1102, [PUBMED], [INFOTRIEVE]
- McDougal J.N. Prediction–Physiological Models. Dermal Absorption and Toxicity Assessment, M.S. Roberts, K.A. Walters. Marcel Dekker, New York 1998
- Jepson G.W., McDougal J.N. Physiologically Based Modeling of Nonsteady State Dermal Absorption of Halogenated Methanes from an Aqueous Solution. Toxicol. Appl. Pharmacol. 1997; 144: 315–324, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Benowitz N.L., Chan K., Denaro C.P., Jacob P. Stable Isotope Method for Studying Transdermal Drug Absorption: Nicotine Patch. Clin. Pharmacol. Ther. 1991; 50(Sept.)286–293, [PUBMED], [INFOTRIEVE]
- Singh P., Maibach H.I., Roberts M.S. Site of Effects. Dermal Absorption and Toxicity Assessment, M.S. Roberts, K.A. Walters. Marcel Dekker, New York 1998
- McNeil S.C., Potts R.O., Francoeur M.L. Local Enhanced Topical Delivery (LETD) of Drugs: Does It Truly Exist?. Pharm. Res. 1992; 9: 1422–1427, [CROSSREF]
- Singh P., Roberts M.S. Blood Flow Measurements in Skin and Underlying Tissues By Microsphere Method: Application to Dermal Pharmacokinetics of Polar Non-Electrolytes. J. Pharm. Sci. 1993; 82(9)873–879, [PUBMED], [INFOTRIEVE]
- Beastall J., Guy R.H., Hadgraft J., Wilding I. The Influence of Urea on Percutaneous Absorption. Pharm. Res. 1986; 3(5)294–297, [CROSSREF]
- Demana P.H., Smith E.W., Walker R.B., Haigh J.M., Kanfer I. Evaluation of the Proposed FDA Pilot Dose-Response Methodology for Topical Corticosteroid Bioequivalence Testing. Pharm. Res. 1997; 14(3)303–308, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Singh G.J., Fleischer N., Lesko L., Williams R. Evaluation of the Proposed FDA Pilot Dose–Response Methodology for Topical Corticosteroid Bioequivalence Testing. Pharm. Res. 1998; 15(1)4–7, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Smith E.W., Walker R.B., Haigh J.M., Kanfer I. Evaluation of the Proposed FDA Pilot Dose–Response Methodology for Topical Corticosteroid Bioequivalence Testing. The Authors Reply. Pharm. Res. 1998; 15(1)5–7
- Kasting G.B. Theoretical Models for Iontophoretic Delivery. Adv. Drug Delivery Rev. 1992; 9: 177–199, [CROSSREF]
- Roberts M.S., Lai P.M., Anissimov Y.G. Ionic Mobility—Pore Model for Iontophoretic Transport. Pharm. Res. 1998; 15(10)1569–1578, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Cross S.E., Roberts M.S. The Importance of Dermal Blood Supply and the Epidermis on the Transdermal Iontophoretic Delivery of Monovalent Cations. J. Pharm. Sci. 1995; 84: 584–592, [PUBMED], [INFOTRIEVE]
- Mitragotri S., Blankschtein D., Langer R. An Explanation for the Variation of the Sonophoretic Transdermal Transport Enhancement from Drug to Drug. J. Pharm. Sci. 1997; 86(10)1190–1192, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Jiang R., Roberts M.S., Collins D.M., Benson H.A.E. Absorption of Sunscreens into Human Skin: An Evaluation of Commercial Products for Children and Adults. Br. J. Clin. Pharmacol. 1998
- Kubota K., Sznitowska M., Maibach H.I. Percutaneous Absorption: A Single-Layer Model. J. Pharm. Sci. 1993; 82(5)450–456, [PUBMED], [INFOTRIEVE]
- Beckett A.H., Gorrod J.W., Taylor D.C. Comparison of Oral and Percutaneous Routes in Man for Systemic Administration of Ephedrine. J. Pharm. Pharmacol. 1972; 24(Suppl.)65–70